Research news

Researchers at UCLH, the Francis Crick Institute, and the UCL Cancer Institute have shown that a test called ORACLE can predict lung cancer survival at the point of diagnosis better than currently used clinical risk factors.

A UCLH patient has received an innovative treatment for radiotherapy-induced dry mouth, an irreversible serious adverse effect of head and neck cancer radiotherapy that causes permanent impairment of talking and eating.

Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

UCLH is the first NHS centre in the UK to offer patients suffering from obstructive sleep apnœa (OSA) a choice of nerve stimulation devices to manage their condition.

UCLH has recruited the first patient to a global trial of an investigational medication for adults with Huntington’s Disease (HD).